RecruitingNCT05729932
Cannabis and opioid effects on withdrawal in people with opioid use disorder
Medication studyAges 18–55United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- LexingtonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 10, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 15
- Sponsor
- Shanna Babalonis, PhD
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT05729932
- Official title
Show the full official title
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Lexington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Shanna Babalonis, PhD.
Does this study involve medication?
Yes. The study involves medication, including Inhaled vaporized cannabis and Intransal opioid.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
